Sort   by:  
 Page size 
GenomicsTreatment of genetic screening of hypertriglyceridemia type I, III, and V - HTG Amsterdam

This is a cohort of patients with extreme hypertriglyceridemia. Patients have been screened for loss of function mutations in LPL, GPIHBP1, APOC2, APOA5 and LMF1.

phs000511.v1.p1 | EGA
GenomicsEGAD00000000026
Randomly-selected, unrelated individuals
EGAD00000000026 | EGA
GenomicsAn immune response network associated with blood lipid levels
Genome-wide genotyping was performed on a population-based cohort from the capital region of Finland using the Illumina 610-Quad SNP microarray
EGAS00000000086 | EGA
GenomicsTHL Biobank Data Access Committee
Data Access Committee EGAC00001000660
EGAC00001000660 | EGA
GenomicsFinnuncorrNLITUK1UK3hap300 - samples
All cases and controls (Hap300)
EGAD00010000298 | EGA
GenomicsFinnuncorrNLITUK3hap550_onlyNBS - samples
NBS control samples only (Hap550)
EGAD00010000290 | EGA
GenomicsFinnuncorrNLITUK1UK3hap300_no1958BC_noNBS - samples
All cases and Finnish, Dutch, Italian control samples (Hap300)
EGAD00010000292 | EGA
GenomicsFinnuncorrNLITUK3hap550_only1958BC - samples
1958BC control samples only (Hap550)
EGAD00010000296 | EGA
GenomicsFinnuncorrNLITUK3hap550_no1958BC_noNBS - samples
All cases and Finnish, Dutch, Italian control samples (Hap550)
EGAD00010000288 | EGA
GenomicsFinnuncorrNLITUK1UK3hap300_onlyNBS - samples
NBS control samples only (Hap300)
EGAD00010000284 | EGA
Sort   by:  
 Page size